Clovis Oncology IPO Research Information

Clovis Oncology IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Clovis Oncology, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Clovis Oncology	CLVS - NASDAQ	$13.00-$15.00	$13.00	$13.05	9.3 million	11/16/2011
Underwriter(s): J.P. Morgan, Credit Suisse
Co-Manager(s): Leerink
Industry: Health Care
Filing(s): Amendment 2011-08-31 Terms Added 2011-10-31

Clovis Oncology Quote & Chart - Click for current quote - CLVS

About Clovis Oncology (adapted from Clovis Oncology prospectus):
They are a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets.

This description is adapted from Clovis prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Clovis "CLVS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.